Cargando…

Homologous Recombination Deficiency Scar: Mutations and Beyond—Implications for Precision Oncology

SIMPLE SUMMARY: A characteristic across several cancer types is a homologous recombination deficiency (HRD). HRD is associated with a better response to several anticancer therapies. Adequate assessment of HRD can therefore improve the outcome of such therapies. However, current methods to assess HR...

Descripción completa

Detalles Bibliográficos
Autores principales:	van der Wiel, Alexander M. A., Schuitmaker, Lesley, Cong, Ying, Theys, Jan, Van Hoeck, Arne, Vens, Conchita, Lambin, Philippe, Yaromina, Ala, Dubois, Ludwig J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9454578/ https://www.ncbi.nlm.nih.gov/pubmed/36077694 http://dx.doi.org/10.3390/cancers14174157

Ejemplares similares

Human fibronectin extra domain B as a biomarker for targeted therapy in cancer
por: Lieverse, Relinde I. Y., et al.
Publicado: (2020)

Hypoxia PET Imaging with [18F]-HX4—A Promising Next-Generation Tracer
por: Sanduleanu, Sebastian, et al.
Publicado: (2020)

Releasing the brakes of tumor immunity with anti-PD-L1 and pushing its accelerator with L19–IL2 cures poorly immunogenic tumors when combined with radiotherapy
por: Olivo Pimentel, Veronica, et al.
Publicado: (2021)

Evofosfamide sensitizes esophageal carcinomas to radiation without increasing normal tissue toxicity
por: Spiegelberg, Linda, et al.
Publicado: (2019)

Prognostic Significance of Carbonic Anhydrase IX Expression in Cancer Patients: A Meta-Analysis
por: van Kuijk, Simon J. A., et al.
Publicado: (2016)

Combining hypoxia-activated prodrugs and radiotherapy in silico: Impact of treatment scheduling and the intra-tumoural oxygen landscape
por: Hamis, Sara, et al.
Publicado: (2020)

Combining radiotherapy with immunotherapy: the past, the present and the future
por: Van Limbergen, Evert J, et al.
Publicado: (2017)

Hypoxia-activated prodrugs and (lack of) clinical progress: The need for hypoxia-based biomarker patient selection in phase III clinical trials
por: Spiegelberg, Linda, et al.
Publicado: (2019)

Charged Particle and Conventional Radiotherapy: Current Implications as Partner for Immunotherapy
por: Marcus, Damiënne, et al.
Publicado: (2021)

Polyphenols as Potential Protectors against Radiation-Induced Adverse Effects in Patients with Thoracic Cancer
por: Prades-Sagarra, Èlia, et al.
Publicado: (2023)

In vivo optical imaging of MMP2 immuno protein antibody: tumor uptake is associated with MMP2 activity
por: Panth, Kranthi Marella, et al.
Publicado: (2016)

Synergistic Effects of NOTCH/γ-Secretase Inhibition and Standard of Care Treatment Modalities in Non-small Cell Lung Cancer Cells
por: Sosa Iglesias, Venus, et al.
Publicado: (2018)

Pan-cancer landscape of homologous recombination deficiency
por: Nguyen, Luan, et al.
Publicado: (2020)

Efficient Secretion of Murine IL-2 From an Attenuated Strain of Clostridium sporogenes, a Novel Delivery Vehicle for Cancer Immunotherapy
por: Kubiak, Aleksandra M., et al.
Publicado: (2021)

Prognostic Role of Hypoxia-Inducible Factor-2α Tumor Cell Expression in Cancer Patients: A Meta-Analysis
por: Moreno Roig, Eloy, et al.
Publicado: (2018)

The immunocytokine L19-IL2: An interplay between radiotherapy and long-lasting systemic anti-tumour immune responses
por: Rekers, Nicolle H., et al.
Publicado: (2018)

Artificial intelligence for precision oncology: beyond patient stratification
por: Azuaje, Francisco
Publicado: (2019)

The Sulfamate Small Molecule CAIX Inhibitor S4 Modulates Doxorubicin Efficacy
por: van Kuijk, Simon J. A., et al.
Publicado: (2016)

Nitroglycerin as a radiosensitizer in non-small cell lung cancer: Results of a prospective imaging-based phase II trial
por: Reymen, Bart J.T., et al.
Publicado: (2019)

Novel fluorinated carbonic anhydrase IX inhibitors reduce hypoxia-induced acidification and clonogenic survival of cancer cells
por: Kazokaitė, Justina, et al.
Publicado: (2018)

Precision Oncology Beyond Genomics: The Future Is Here—It Is Just Not Evenly Distributed
por: Pfohl, Ulrike, et al.
Publicado: (2021)

Italian Precision Medicine in Pediatric Oncology: Moving beyond Actionable Alterations
por: Pastorino, Fabio, et al.
Publicado: (2022)

Selectively Targeting Tumor Hypoxia With the Hypoxia-Activated Prodrug CP-506
por: van der Wiel, Alexander M.A., et al.
Publicado: (2021)

Artificial Intelligence to Decode Cancer Mechanism: Beyond Patient Stratification for Precision Oncology
por: Patel, Sandip Kumar, et al.
Publicado: (2020)

Efficacy of gene therapy-delivered cytosine deaminase is determined by enzymatic activity but not expression
por: Dubois, L, et al.
Publicado: (2007)

Spores of Clostridium engineered for clinical efficacy and safety cause regression and cure of tumors in vivo
por: Heap, John T., et al.
Publicado: (2014)

Metabolic Rewiring in Radiation Oncology Toward Improving the Therapeutic Ratio
por: van Gisbergen, Marike W., et al.
Publicado: (2021)

Homologous Recombination: To Fork and Beyond
por: Prado, Félix
Publicado: (2018)

Future paradigms for precision oncology
por: Klement, Giannoula Lakka, et al.
Publicado: (2016)

Actionability and precision oncology
por: Schwaederle, Maria, et al.
Publicado: (2015)

Bioinformatics for precision oncology
por: Singer, Jochen, et al.
Publicado: (2017)

The Future of Precision Oncology
por: Rulten, Stuart L., et al.
Publicado: (2023)

Moving beyond the glial scar for spinal cord repair
por: Bradbury, Elizabeth J., et al.
Publicado: (2019)

An Emerging Role for Radiation Oncology in Precision Oncology
por: Goyal, Sharad, et al.
Publicado: (2016)

Relationship between homologous recombination deficiency and clinical features of breast cancer based on genomic scar score()
por: Feng, Cong, et al.
Publicado: (2023)

Advancing Clostridia to Clinical Trial: Past Lessons and Recent Progress
por: Mowday, Alexandra M., et al.
Publicado: (2016)

How can we deliver on the promise of precision medicine in oncology and beyond? A practical roadmap for action
por: Baird, Anne‐Marie, et al.
Publicado: (2023)

Homologs of SCAR/WAVE complex components are required for epidermal cell morphogenesis in rice
por: Zhou, Wenqi, et al.
Publicado: (2016)

Preoperative Marking to Approximate Forehead Rhytids for Precisely Camouflaging Scars
por: Cerci, Felipe B., et al.
Publicado: (2023)

Homologous Recombination Deficiency (HRD) in Cutaneous Oncology
por: Akinjiyan, Favour A., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_gncq6kjivbtcp5cpvol8s1hb5o